357 related articles for article (PubMed ID: 27562241)
1. Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study.
Zhang S; Palazuelos-Munoz S; Balsells EM; Nair H; Chit A; Kyaw MH
BMC Infect Dis; 2016 Aug; 16(1):447. PubMed ID: 27562241
[TBL] [Abstract][Full Text] [Related]
2. Hospitalization stay and costs attributable to Clostridium difficile infection: a critical review.
Gabriel L; Beriot-Mathiot A
J Hosp Infect; 2014 Sep; 88(1):12-21. PubMed ID: 24996516
[TBL] [Abstract][Full Text] [Related]
3. Inpatient Expenditures Attributable to Hospital-Onset Clostridium difficile Infection: A Nationwide Case-Control Study in Japan.
Fukuda H; Yano T; Shimono N
Pharmacoeconomics; 2018 Nov; 36(11):1367-1376. PubMed ID: 30022364
[TBL] [Abstract][Full Text] [Related]
4. Economic healthcare costs of Clostridium difficile infection: a systematic review.
Ghantoji SS; Sail K; Lairson DR; DuPont HL; Garey KW
J Hosp Infect; 2010 Apr; 74(4):309-18. PubMed ID: 20153547
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of fixed and variable hospital costs due to Clostridium difficile infection: institutional incentives and directions for future research.
Ryan P; Skally M; Duffy F; Farrelly M; Gaughan L; Flood P; McFadden E; Fitzpatrick F
J Hosp Infect; 2017 Apr; 95(4):415-420. PubMed ID: 28320542
[TBL] [Abstract][Full Text] [Related]
6. Burden of Clostridium difficile Infections in French Hospitals in 2014 From the National Health Insurance Perspective.
Leblanc S; Blein C; Andremont A; Bandinelli PA; Galvain T
Infect Control Hosp Epidemiol; 2017 Aug; 38(8):906-911. PubMed ID: 28756805
[TBL] [Abstract][Full Text] [Related]
7. Economic burden of primary compared with recurrent Clostridium difficile infection in hospitalized patients: a prospective cohort study.
Shah DN; Aitken SL; Barragan LF; Bozorgui S; Goddu S; Navarro ME; Xie Y; DuPont HL; Garey KW
J Hosp Infect; 2016 Jul; 93(3):286-9. PubMed ID: 27209056
[TBL] [Abstract][Full Text] [Related]
8. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach.
Desai K; Gupta SB; Dubberke ER; Prabhu VS; Browne C; Mast TC
BMC Infect Dis; 2016 Jun; 16():303. PubMed ID: 27316794
[TBL] [Abstract][Full Text] [Related]
9. Burden of Clostridium (Clostridioides) difficile infection during inpatient stays in the USA between 2012 and 2016.
Mollard S; Lurienne L; Heimann SM; Bandinelli PA
J Hosp Infect; 2019 Jun; 102(2):135-140. PubMed ID: 30690052
[TBL] [Abstract][Full Text] [Related]
10. Attributable Cost of Clostridium difficile Infection in Pediatric Patients.
Mehrotra P; Jang J; Gidengil C; Sandora TJ
Infect Control Hosp Epidemiol; 2017 Dec; 38(12):1472-1477. PubMed ID: 29173236
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile infection in patients hospitalized with type 2 diabetes mellitus and its impact on morbidity, mortality, and the costs of inpatient care.
Olanipekun TO; Salemi JL; Mejia de Grubb MC; Gonzalez SJ; Zoorob RJ
Diabetes Res Clin Pract; 2016 Jun; 116():68-79. PubMed ID: 27321318
[TBL] [Abstract][Full Text] [Related]
12. Excess length of hospital stay, mortality and cost attributable to
Kimura T; Stanhope S; Sugitani T
Epidemiol Infect; 2020 Mar; 148():e65. PubMed ID: 32115019
[TBL] [Abstract][Full Text] [Related]
13. Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States.
Zhang D; Prabhu VS; Marcella SW
Clin Infect Dis; 2018 Apr; 66(9):1326-1332. PubMed ID: 29360950
[TBL] [Abstract][Full Text] [Related]
14. Hospital cost of Clostridium difficile infection including the contribution of recurrences in French acute-care hospitals.
Le Monnier A; Duburcq A; Zahar JR; Corvec S; Guillard T; Cattoir V; Woerther PL; Fihman V; Lalande V; Jacquier H; Mizrahi A; Farfour E; Morand P; Marcadé G; Coulomb S; Torreton E; Fagnani F; Barbut F;
J Hosp Infect; 2015 Oct; 91(2):117-22. PubMed ID: 26253518
[TBL] [Abstract][Full Text] [Related]
15. The impact of Clostridium difficile infection on resource use and costs in hospitals in Spain and Italy: a matched cohort study.
Asensio A; Di Bella S; Lo Vecchio A; Grau S; Hart WM; Isidoro B; Scotto R; Petrosillo N; Watt M; Nazir J
Int J Infect Dis; 2015 Jul; 36():31-8. PubMed ID: 26003403
[TBL] [Abstract][Full Text] [Related]
16. Trend, Risk Factors, and Costs of Clostridium difficile Infections in Vascular Surgery.
Egorova NN; Siracuse JJ; McKinsey JF; Nowygrod R
Ann Vasc Surg; 2015; 29(4):792-800. PubMed ID: 25595110
[TBL] [Abstract][Full Text] [Related]
17. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection.
Rodrigues R; Barber GE; Ananthakrishnan AN
Infect Control Hosp Epidemiol; 2017 Feb; 38(2):196-202. PubMed ID: 27817758
[TBL] [Abstract][Full Text] [Related]
18. The economic burden of Clostridium difficile.
McGlone SM; Bailey RR; Zimmer SM; Popovich MJ; Tian Y; Ufberg P; Muder RR; Lee BY
Clin Microbiol Infect; 2012 Mar; 18(3):282-9. PubMed ID: 21668576
[TBL] [Abstract][Full Text] [Related]
19. Cost analysis of an outbreak of Clostridium difficile infection ribotype 027 in a Dutch tertiary care centre.
van Beurden YH; Bomers MK; van der Werff SD; Pompe EAPM; Spiering S; Vandenbroucke-Grauls CMJE; Mulder CJJ
J Hosp Infect; 2017 Apr; 95(4):421-425. PubMed ID: 28169013
[TBL] [Abstract][Full Text] [Related]
20. Burden of Clostridium difficile infection: Associated hospitalization in a cohort of middle-aged and older adults.
Chen Y; Glass K; Liu B; Korda RJ; Riley TV; Kirk MD
Am J Infect Control; 2017 May; 45(5):508-511. PubMed ID: 28089675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
